Royal Bank of Canada
BLPH

Royal Bank of Canada’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Royal Bank of Canada’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-192
Closed – – 7986
2023
Q2 		$0 Buy
192
+180
+1,500% +$1.16K ﹤0.01% 8013
2023
Q1 		$0 Sell
12
-67
-85% -$233 ﹤0.01% 7869
2022
Q4 		$0 Sell
79
-174
-69% -$178 ﹤0.01% 8218
2022
Q3 		$0 Hold
253
– – ﹤0.01% 8277
2022
Q2 		$0 Sell
253
-2
-0.8% -$3 ﹤0.01% 8235
2022
Q1 		$1K Sell
255
-2,174
-90% -$5.17K ﹤0.01% 7682
2021
Q4 		$7K Buy
2,429
+2,255
+1,296% +$7.49K ﹤0.01% 7162
2021
Q3 		$1K Sell
174
-709
-80% -$2.96K ﹤0.01% 7581
2021
Q2 		$4K Buy
883
+453
+105% +$2.03K ﹤0.01% 7164
2021
Q1 		$2K Buy
+430
New +$3K ﹤0.01% 7282
2019
Q1 		– Sell
-4
Closed – – 7289
2018
Q4 		$0 Sell
4
-66
-94% -$958 ﹤0.01% 7397
2018
Q3 		$1K Buy
70
+3
+4% +$71 ﹤0.01% 6645
2018
Q2 		$2K Sell
67
-4,657
-99% -$161K ﹤0.01% 6307
2018
Q1 		$147K Sell
4,724
-294
-6% -$9.35K ﹤0.01% 4486
2017
Q4 		$194K Buy
+5,018
New +$132K ﹤0.01% 4446
2017
Q3 		– Hold
0
– – – 7157
2017
Q1 		– Sell
-12
Closed – – 6944
2016
Q4 		$0 Hold
12
– – ﹤0.01% 6880
2016
Q3 		$0 Hold
12
– – ﹤0.01% 6684
2016
Q2 		$0 Buy
+12
New +$329 ﹤0.01% 6639
2016
Q1 		– Hold
0
– – – 6822

Other funds holding BLPH

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's BLPH Position: Q3 2023 in Review

Royal Bank of Canada sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2023, closing a stake of 192 shares.

Royal Bank of Canada first reported a position in BLPH in Q2 2016 and held it in 18 quarters. The position peaked at $194K in Q4 2017. 22 funds tracked by Wall St. Rank hold BLPH as of Q3 2023.

  • Royal Bank of Canada reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 192 Bellerophon Therapeutics, Inc. shares in Q3 2023.
  • Royal Bank of Canada first reported a position in Bellerophon Therapeutics, Inc. in Q2 2016 and held it in 18 quarters.
  • Royal Bank of Canada's Bellerophon Therapeutics, Inc. position peaked at $194K in Q4 2017.
  • 22 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.